hat
Anplis de sa, MMAD se rapòte yo dwe itilize nan pwodiksyon an nan sit-espesifik konjige dwòg antikò (NDCs). Nan NDCs yo, MMAD konbine avèk anti-5T4 antikò oswa anti-Her2 antikò. Li montre ke NDCs yo demontre pi bon efikasite ak pharmacokinetics.
eng
Additionally, MMAD is reported to be used in the production of site-specific antibody drug conjugates (NDCs). In the NDCs, MMAD is combined with anti-5T4 antibody or anti-Her2 antibody. It is shown that the NDCs demonstrate better efficacy and pharmacokinetics.